Maria Lucia Narducci
Overview
Explore the profile of Maria Lucia Narducci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
877
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narducci M, Ballacci F, Giordano F, Collini V, Imazio M
Open Heart
. 2025 Jan;
11(2).
PMID: 39882569
Background: Ventricular arrhythmias (VAs) frequently occur in the acute phase of myocarditis. Possible arrhythmic recurrences and the risk of sudden cardiac death (SCD) in this setting are reasons for concern,...
2.
Perna F, Flore F, Telesca A, Ruscio E, Scacciavillani R, Bencardino G, et al.
Pacing Clin Electrophysiol
. 2024 Dec;
48(1):9-20.
PMID: 39739592
Introduction: Ultrasound (US)-guided axillary vein puncture is a safe and effective approach for cardiac implantable electronic device (CIED) implantation, and it is highly recommended by the current consensus document. However,...
3.
Narducci M, Pecori D, Imazio M, Rebellato L, Geminiani M, Bontempo G, et al.
New Microbiol
. 2024 Nov;
47(3):292-294.
PMID: 39560043
The time of re-implantation of removed CIED for local infection or endocarditis has been debated because no randomized studies are available. Many authors prefer to delay reimplantation to the time...
4.
Bencardino G, Narducci M, Scacciavillani R, Gabrielli F, Pelargonio G, Massetti M, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39201099
Catheter ablation (CA) is a well-established treatment in patients with ventricular tachycardia and appropriate implantable cardioverter defibrillator (ICD) therapies. We enrolled 57 consecutive carriers of ICD undergoing CA for electrical...
5.
Narducci M, Scacciavillani R, Nano R, Bisignani A, DAlessandris N, Inzani F, et al.
Int J Cardiol
. 2024 Aug;
416:132489.
PMID: 39187071
A wide variety of non-invasive and invasive techniques for SCD risk stratification in non ischemic cardiomyopathy (NICM) have been proposed, including left ventricular (LV) ejection fraction, QRS duration, late gadolinium...
6.
Scacciavillani R, Koliastasis L, Doundoulakis I, Chiotis S, Kordalis A, Narducci M, et al.
J Cardiovasc Dev Dis
. 2024 Jul;
11(7).
PMID: 39057629
Cardiac implantable electronic devices (CIEDs) offer the benefit of remote monitoring and decision making and find particular applications in special populations such as the elderly. Less transportation, reduced costs, prompt...
7.
Narducci M, Nurchis M, Ballacci F, Giordano F, Calabro G, Massetti M, et al.
ESC Heart Fail
. 2023 Nov;
11(1):229-239.
PMID: 37943287
Aims: Cardiac contractility modulation (CCM) is a device therapy for heart failure, based on the delivery of high-voltage biphasic impulses to the right ventricular septum during the myocardial absolute refractory...
8.
Flore F, Scacciavillani R, Iannaccone G, Narducci M, Pinnacchio G, Bencardino G, et al.
Future Cardiol
. 2023 Nov;
19(14):707-718.
PMID: 37929680
Recently, prognosis and survival of cancer patients has improved due to progression and refinement of cancer therapies; however, cardiovascular sequelae in this population augmented and now represent the second cause...
9.
Narducci M, Liuzzo G
Eur Heart J
. 2023 Aug;
44(39):3946-3947.
PMID: 37650261
No abstract available.
10.